OSR Health, Inc. (OSRHW) EBITDA Margin (2024 - 2026)

OSR Health (OSRHW) has 3 years of EBITDA Margin data on file, last reported at 757.59% in Q1 2026.

• For the quarter ending Q1 2026, EBITDA Margin fell 37431.0% year-over-year to 757.59%; the trailing twelve-month figure through Mar 2026 stood at 726.07% (down 39173.0% YoY), and the FY2025 full-year result was 631.01%, down 29988.0% from the prior year.
• EBITDA Margin rose to 757.59% in Q1 2026, from 1674.81% in the prior quarter.
• In the past five years, EBITDA Margin ranged from a high of 176.0% in Q4 2024 to a low of 1674.81% in Q4 2025.
• A 3-year average of 579.81% and a median of 433.36% in 2024 frame the typical range for EBITDA Margin.
• Peak annual rise in EBITDA Margin reached 2046 bps in 2025, while the deepest fall reached 149881 bps in 2025.
• Tracing OSRHW's EBITDA Margin over 3 years: stood at 176.0% in 2024, then tumbled by 852 bps to 1674.81% in 2025, then jumped by 55 bps to 757.59% in 2026.
• Business Quant data shows OSRHW's EBITDA Margin at 757.59% in Q1 2026, 1674.81% in Q4 2025, and 605.89% in Q3 2025.